Education
About Us
Working with TipRanks
Follow Us
IMCD N.V. (DE:INX)
XETRA:INX
INX Stock Chart & Stats
€85.32
-€0.55(-0.39%)
At close: 4:00 PM EST
€85.32
-€0.55(-0.39%)
Day’s Range― - ―
52-Week Range€72.36 - €146.85
Previous CloseN/A
Volume0.00
Average Volume (3M)76.00
Market Cap
€5.00B
Enterprise Value€6.50B
Total Cash (Recent Filing)€238.59M
Total Debt (Recent Filing)€1.70B
Price to Earnings (P/E)22.0
Beta0.58
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.39
Shares Outstanding59,107,998
10 Day Avg. Volume138
30 Day Avg. Volume76
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)2.24
Price to Sales (P/S)0.96
P/FCF Ratio14.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€104.00Price Target Upside21.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Specialty Distribution & PartnershipsIMCD's broad product portfolio and global distribution across pharma, personal care, food and industrial end markets creates durable demand diversification. Strategic manufacturer partnerships and technical support capabilities bolster sticky customer relationships and cross-sell opportunities over multi-year cycles.
High-quality Free Cash Flow GenerationConsistent near one-to-one FCF versus net income and a 2025 rebound indicate strong cash conversion and earnings quality. Durable free cash flow supports reinvestment, dividend funding, debt service or targeted M&A, providing financial flexibility even if margins fluctuate.
Historical Revenue Growth And Resilient ProfitabilityMulti-year top-line expansion through 2024 demonstrates structural market demand for specialty distribution. Even with 2025 softness, continued operating profitability reflects a resilient, margin-bearing distribution model and value-added services that can sustain earnings over the medium term.
Bears Say
2025 Margin Compression And Revenue DipA clear 2025 revenue decline and material gross-to-net margin step-down suggest weakening pricing power or adverse mix. If sustained, margin erosion will reduce cash available for reinvestment, increase sensitivity to cost shocks, and compress long-term earnings potential absent remediation.
Rising Leverage Reduces FlexibilityDebt-to-equity moving into the ~0.7–0.8x range constrains capacity for opportunistic M&A, makes the company more sensitive to interest costs, and limits room to absorb cycles or fund turnarounds. Higher leverage exacerbates risk if margins remain pressured.
Earnings Contraction And Declining Return MetricsA sharp EPS contraction signals near-term profit deterioration; paired with a noted ROE trend down in the filings, this suggests reduced capital efficiency. Sustained EPS weakness can constrain reinvestment, limit dividend growth, and weaken competitive positioning over time.
IMCD N.V. News
INX FAQ
What was IMCD N.V.’s price range in the past 12 months?
IMCD N.V. lowest stock price was €72.36 and its highest was €146.85 in the past 12 months.
What is IMCD N.V.’s market cap?
IMCD N.V.’s market cap is €5.00B.
When is IMCD N.V.’s upcoming earnings report date?
IMCD N.V.’s upcoming earnings report date is Apr 30, 2026 which is in 68 days.
How were IMCD N.V.’s earnings last quarter?
IMCD N.V. released its earnings results on Feb 18, 2026. The company reported €2.39 earnings per share for the quarter, the consensus estimate of €2.39 by €0.
Is IMCD N.V. overvalued?
According to Wall Street analysts IMCD N.V.’s price is currently Undervalued.
Does IMCD N.V. pay dividends?
IMCD N.V. does not currently pay dividends.
What is IMCD N.V.’s EPS estimate?
IMCD N.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IMCD N.V. have?
IMCD N.V. has 59,107,998 shares outstanding.
What happened to IMCD N.V.’s price movement after its last earnings report?
IMCD N.V. reported an EPS of €2.39 in its last earnings report, expectations of €2.39. Following the earnings report the stock price went down -8.866%.
Which hedge fund is a major shareholder of IMCD N.V.?
Currently, no hedge funds are holding shares in DE:INX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IMCD N.V.
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
INX Stock 12 Month Forecast
Average Price Target
€104.00
▲(21.89% Upside)
Technical Analysis
Options Prices
Currently, No data available
---